CD14 and acute myeloid leukemia: In summary, the cellular morphology determined on blood smear examination, together with the percentage of circulating immature cells (≥20%) from the CBC differential and the immunophenotype of the neoplastic cells (>3.0% CD14+MHCII cells) documented on flow cytometry, supported the diagnosis of AML, with AML‐M4 considered more likely.3, 4